Satoshi Okayama Selected Research

Calcium

8/2014

Colocalization of thin-cap fibroatheroma and spotty calcification is a powerful predictor of procedure-related myocardial injury after elective coronary stent implantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoshi Okayama Research Topics

Disease

14	Heart Failure 01/2022 - 12/2009
8	Myocardial Infarction 01/2019 - 04/2006
6	Atherosclerotic Plaque (Atheroma) 01/2020 - 12/2009
5	Chronic Renal Insufficiency 10/2019 - 06/2013
5	Atherosclerosis 10/2019 - 12/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2006
3	Fibrosis (Cirrhosis) 11/2016 - 01/2010
3	Hypertrophy 11/2016 - 04/2010
3	Pathologic Constriction (Stenosis) 09/2015 - 01/2012
2	Acute Coronary Syndrome 01/2020 - 01/2011
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2019 - 12/2012
2	Cardio-Renal Syndrome 01/2019 - 01/2013
2	Thrombosis (Thrombus) 08/2016 - 12/2009
2	Inflammation (Inflammations) 11/2015 - 01/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015 - 01/2013
2	Infarction (Infarctions) 08/2007 - 04/2006
1	Edema (Dropsy) 11/2022
1	Atrial Fibrillation 01/2022
1	Anemia 01/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020
1	Diabetes Mellitus 01/2020
1	Takotsubo Cardiomyopathy 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 05/2017
1	Cardiomegaly (Heart Hypertrophy) 11/2016
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 06/2015
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2015
1	Necrosis 01/2014
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2014
1	Stroke (Strokes) 06/2013
1	Embolism (Embolus) 01/2013
1	Dyspnea (Shortness of Breath) 12/2012
1	Lacerations 01/2012
1	Sepsis (Septicemia) 01/2011
1	Renal Insufficiency (Renal Failure) 12/2009
1	Nephrogenic Fibrosing Dermopathy 01/2009
1	Stable Angina 10/2008
1	Hyperplasia 10/2008
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 09/2008

Drug/Important Bio-Agent (IBA)

9	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2019 - 04/2006
5	CytokinesIBA 10/2019 - 10/2008
4	Tyrosine (L-Tyrosine)FDA Link 02/2014 - 12/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 12/2009
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 04/2010
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2009
3	AldosteroneIBA 11/2016 - 01/2006
3	Indicators and Reagents (Reagents)IBA 01/2015 - 01/2013
2	salicylhydroxamic acid (SHAM)IBA 10/2019 - 04/2006
2	ReninIBA 01/2019 - 01/2015
2	ApolipoproteinsIBA 02/2014 - 12/2009
2	LipidsIBA 01/2012 - 01/2011
2	GadoliniumIBA 01/2011 - 01/2009
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2022
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	IronIBA 01/2021
1	Docosahexaenoic AcidsIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	Eicosapentaenoic AcidIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	AST 120IBA 10/2019
1	Uremic ToxinsIBA 10/2019
1	CarbonIBA 10/2019
1	omega-Chloroacetophenone (Mace)IBA 01/2019
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018
1	CatecholaminesIBA 01/2018
1	GTP-Binding Proteins (G-Protein)IBA 01/2018
1	Lipocalin-2IBA 05/2017
1	SodiumIBA 11/2016
1	SaltsIBA 11/2016
1	Phenobarbital (Luminal)FDA Link 09/2015
1	DiureticsIBA 06/2015
1	Tolvaptan FDA Link 06/2015
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	Serum AlbuminIBA 01/2015
1	CalciumIBA 08/2014
1	Apolipoproteins E (ApoE)IBA 02/2014
1	Heparin (Liquaemin)FDA LinkGeneric 02/2014
1	Amyloid (Amyloid Fibrils)IBA 01/2014
1	Peptides (Polypeptides)IBA 06/2013
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2011
1	AcidsIBA 01/2010
1	ChloridesIBA 01/2010
1	Contrast MediaIBA 01/2009
1	MetalsIBA 10/2008
1	Sirolimus (Rapamycin)FDA Link 10/2008
1	3-Iodobenzylguanidine (Iobenguane)IBA 09/2008
1	technetium tc-99m tetrofosmin (Myoview)FDA Link 08/2007

Therapy/Procedure

6	Stents 08/2016 - 10/2008
2	Therapeutics 01/2020 - 12/2009
2	Drug-Eluting Stents 08/2016 - 12/2009
2	Renal Dialysis (Hemodialysis) 06/2013 - 12/2012
1	Catheter Ablation 01/2022
1	Patient Readmission 01/2020
1	Peritoneal Dialysis 05/2016
1	Hemodiafiltration 01/2014
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2013
1	Catheters 01/2013
1	Percutaneous Coronary Intervention 01/2012
1	Transplantation 08/2007